NCT05582304: A reported trial by Johnson & Johnson Vision Care, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05582304 |
|---|---|
| Title | Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 31, 2022 |
| Completion date | Dec. 8, 2022 |
| Required reporting date | Dec. 8, 2023, midnight |
| Actual reporting date | Nov. 20, 2023 |
| Date last checked at ClinicalTrials.gov | July 24, 2025 |
| Days late | None |